A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC)

NCT04742153 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
66
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Miracogen Inc.